Once KIFC1 activated abnormally, it was able to promote the epithelial-mesenchymal transition (EMT), chemo-resistance, and proliferation of hepatoma cells, thereby facilitating HCC progression both in vitro and in vivo. Here, KIFC1 is linked to hepatocellular carcinoma.